Evidence map›Paper›PMID 41578605›Full record

ArticleChemistry, an Asian journal2026

Fabrication of Nanoporous Silica Membranes by Atmospheric-Pressure Plasma-Enhanced Chemical Vapor Deposition Using Porogen Approach.

Ghulam Muhammad, Hiroki Nagasawa, Tatsuhito Hamura, Norihiro Moriyama, Toshinori Tsuru, Masakoto Kanezashi

Abstract read
In one paragraph

Article in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ghulam MuhammadChemical Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University, Higashi-hiroshima, Hiroshima, Japan.
Hiroki NagasawaChemical Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University, Higashi-hiroshima, Hiroshima, Japan.ORCID https://orcid.org/0000-0001-7972-2425
Tatsuhito HamuraChemical Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University, Higashi-hiroshima, Hiroshima, Japan.
Norihiro MoriyamaChemical Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University, Higashi-hiroshima, Hiroshima, Japan.
Toshinori TsuruChemical Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University, Higashi-hiroshima, Hiroshima, Japan.
Masakoto KanezashiChemical Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University, Higashi-hiroshima, Hiroshima, Japan.

Funding

JSPS KAKENHI 23K23119
6 · The paper itself

Abstract

The development of nanoporous membranes with high selectivity and stability is essential for advanced molecular separation. In this study, nanoporous silica membranes were fabricated via atmospheric-pressure plasma-enhanced chemical vapor deposition (AP-PECVD), using hexamethyldisiloxane (HMDSO) as the precursor and methyl methacrylate (MMA) as the porogen. The hybrid composite structure was precisely controlled by adjusting deposition parameters, including deposition temperature, HMDSO concentration, and MMA/HMDSO ratio. Subsequent thermal treatment at 400°C effectively removed the porogen, yielding stable nanoporous structures with pore sizes of approximately 1 nm. Nanofiltration performance was evaluated using solutes of different molecular weights. The membranes exhibited a sharp molecular weight cutoff (∼340 g/mol), with negligible rejection of azobenzene (182 g/mol) but strong rejection (> 95%) of Basic Red 2 (351 g/mol), Brilliant Blue R (826 g/mol), and vitamin B12 (1355 g/mol). The membranes maintained stable flux values in the range of 14-15.5 kg/(m

Indexed as

atmospheric‐pressure plasmananofiltrationnanoporous silica membraneplasma‐enhanced chemical vapor depositionporogen approach

Identifiers

PMID41578605
PMCPMC12831009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.